Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human EPH Receptor B1 Antibodies:
anti-Mouse (Murine) EPH Receptor B1 Antibodies:
anti-Rat (Rattus) EPH Receptor B1 Antibodies:
Go to our pre-filtered search.
Human Polyclonal EPH Receptor B1 Primary Antibody for IHC (p), WB - ABIN391917
Prevost, Woulfe, Tanaka, Brass: Interactions between Eph kinases and ephrins provide a mechanism to support platelet aggregation once cell-to-cell contact has occurred. in Proceedings of the National Academy of Sciences of the United States of America 2002
Show all 3 Pubmed References
Rat (Rattus) Polyclonal EPH Receptor B1 Primary Antibody for CyTOF, FACS - ABIN4899356
Bush, Soriano: Ephrin-B1 regulates axon guidance by reverse signaling through a PDZ-dependent mechanism. in Genes & development 2009
Mouse (Murine) Polyclonal EPH Receptor B1 Primary Antibody for ICC, IF - ABIN152616
Dravis, Henkemeyer: Ephrin-B reverse signaling controls septation events at the embryonic midline through separate tyrosine phosphorylation-independent signaling avenues. in Developmental biology 2011
SUMOylation of EphB1 repressed activation of its downstream signaling molecule PKC-gamma (show PRKCG Antibodies), and consequently inhibited neuroblastoma (show ARHGEF16 Antibodies) tumorigenesis.
some of the mutations found in EPHB1 may contribute to an increased invasive capacity of cancers.
Association of EPHB1 rs11918092 with symptoms of schizophrenia in Chinese Zhuang and Han populations.
The tumor-suppressor function of EphB1 is clinically relevant across many malignancies, suggesting that EphB1 is an important regulator of common cancer cell transforming pathways.
In medulloblastoma cell lines, EphB1 downregulation or knockdown reduced cell growth, viability, cell-cycle regulator expression, and migration, but increased radiosensitivity and the percentage of cells in G1 phase of the cell cycle.
Our results indicate that EphB1 may be involved in carcinogenesis of renal cell carcinoma (show MOK Antibodies)
The genes CD248 (show CD248 Antibodies), Ephb1 and P2RY2 (show P2RY2 Antibodies) were detected as the top overexpressed in GC biopsies.
The study presents the first structure of the EphB1 tyrosine kinase (show TXK Antibodies) domain determined by X-ray crystallography to 2.5A.
EphB1 and Ephrin-B could be regarded as independent good prognostic factors and important biological markers for Squamous cell/adenosquamous carcinoma and adenocarcinoma of gallbladder.
Our data indicate that loss of EphB1 protein is associated with metastasis and poorer survival in patients with serous ovarian cancer
Findings suggest that a combination of forward and reverse EphB1/2 receptor-mediated signaling contribute to posterior branch of the anterior commissure and corpus callosum axon guidance
During re-epithelialization ephrin-B1 (show EFNB1 Antibodies) and its receptor EphB2 (show EPHB2 Antibodies) are both upregulated in vivo, just for the duration of repair.
In a genetic medulloblastoma model, EphB1 knockout resulted in a significant delay in tumor recurrence following irradiation compared to EphB1-expressing control tumors.
EphB1 expression is activated in the spinal cord in a bone cancer model.
The studies introduce EphB1 as a new venous-restricted marker in a tissue-specific and time-dependent manner.
Reelin (show RELN Antibodies) induces EphB activation.
role of EphB1 receptors signalling in models of inflammatory and neuropathic pain
ephrin B1 (show EFNB1 Antibodies) has a role in maintaining the structural integrity of the developing cortex and maintaining apical adhesion of neural progenitors
PI3K and PI3K crosstalk to ERK (show EPHB2 Antibodies) signaling contributed to modulation of spinal nociceptive information related to ephrinBs/EphBs.
The inner- and outer-arm dyneins, which bridge between the doublet microtubules in axonemes, are the force-generating proteins responsible for the sliding movement in axonemes. The intermediate and light chains, thought to form the base of the dynein arm, help mediate attachment and may also participate in regulating dynein activity. This gene encodes an intermediate chain dynein, belonging to the large family of motor proteins. Mutations in this gene result in abnormal ciliary ultrastructure and function associated with primary ciliary dyskinesia (PCD) and Kartagener syndrome.
, EPH-like kinase 6
, eph tyrosine kinase 2
, ephrin type-B receptor 1
, neuronally-expressed EPH-related tyrosine kinase
, soluble EPHB1 variant 1
, tyrosine-protein kinase receptor EPH-2
, dynein intermediate chain 1, axonemal
, dynein, axonemal, intermediate polypeptide 1
, immotile cilia syndrome 1
, Elk-like kinase
, Xenopus Elk-like kinase
, ephrin type-B receptor 1-A
, receptor tyrosine kinase
, tyrosine-protein kinase receptor XEK
, ephrin receptor EphB1
, EPH receptor B1
, ephrin receptor EphB1-like
, ephrin type-B receptor 1-like
, ELK-related protein tyrosine kinase
, Eph receptor B2 (ELK-related protein tyrosine kinase)